cyc 202 has been researched along with vx680 in 8 studies
Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (vx680) | Trials (vx680) | Recent Studies (post-2010) (vx680) |
---|---|---|---|---|---|
979 | 7 | 393 | 227 | 3 | 143 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessi, DR; Arthur, JS; Bain, J; Cohen, P; Elliott, M; Hastie, CJ; Klevernic, I; McLauchlan, H; Plater, L; Shpiro, N | 1 |
Atteridge, CE; Campbell, BT; Chan, KW; Ciceri, P; Davis, MI; Edeen, PT; Faraoni, R; Floyd, M; Gallant, P; Herrgard, S; Hunt, JP; Karaman, MW; Lockhart, DJ; Milanov, ZV; Morrison, MJ; Pallares, G; Patel, HK; Pritchard, S; Treiber, DK; Wodicka, LM; Zarrinkar, PP | 1 |
Russu, WA; Shallal, HM | 1 |
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Aiche, S; Bassermann, F; Becker, W; Canevari, G; Casale, E; Depaolini, SR; Ehrlich, HC; Felder, ER; Feuchtinger, A; Garz, AK; Gohlke, BO; Götze, K; Greif, PA; Hahne, H; Heinzlmeir, S; Helm, D; Huenges, J; Jeremias, I; Kayser, G; Klaeger, S; Koch, H; Koenig, PA; Kramer, K; Kuster, B; Médard, G; Meng, C; Petzoldt, S; Polzer, H; Preissner, R; Qiao, H; Reinecke, M; Reiter, K; Rueckert, L; Ruland, J; Ruprecht, B; Schlegl, J; Schmidt, T; Schneider, S; Schoof, M; Spiekermann, K; Tõnisson, N; Vick, B; Vooder, T; Walch, A; Wilhelm, M; Wu, Z; Zecha, J; Zolg, DP | 1 |
Arlot-Bonnemains, Y; Dalbiès-Tran, R; Dupont, J; Mermillod, P; Papillier, P; Pennetier, S; Perreau, C; Prigent, C; Thélie, A; Uzbekov, R; Uzbekova, S | 1 |
Hirotsune, S; Kumamoto, K; Sato, M; Takitoh, T; Toba, S; Wang, CC; Wynshaw-Boris, A | 1 |
Arang, N; Bello, T; Dudgeon, DR; Glennon, EK; Gujral, TS; Kain, HS; Kaushansky, A; Walter, ENF | 1 |
8 other study(ies) available for cyc 202 and vx680
Article | Year |
---|---|
The selectivity of protein kinase inhibitors: a further update.
Topics: Amino Acid Sequence; Animals; Cell Line; Drug Design; Enzyme Activation; Humans; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Recombinant Proteins; Spodoptera | 2007 |
A quantitative analysis of kinase inhibitor selectivity.
Topics: Binding Sites; Enzyme Activation; Humans; Phosphotransferases; Protein Binding; Protein Interaction Mapping; Protein Kinase Inhibitors; Proteome; Quantitative Structure-Activity Relationship | 2008 |
Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Protein Kinases; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2011 |
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
The target landscape of clinical kinase drugs.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cytokines; Drug Discovery; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Lung Neoplasms; Mice; Molecular Targeted Therapy; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proteomics; Xenograft Model Antitumor Assays | 2017 |
Spatio-temporal expression patterns of aurora kinases a, B, and C and cytoplasmic polyadenylation-element-binding protein in bovine oocytes during meiotic maturation.
Topics: Animals; Aurora Kinase A; Aurora Kinase B; Aurora Kinase C; Aurora Kinases; Butadienes; Cattle; CDC2 Protein Kinase; Cyclin B; Cyclin B1; Cytoplasm; Embryo, Mammalian; Female; Fertilization; Meiosis; Metformin; mRNA Cleavage and Polyadenylation Factors; Nitriles; Oocytes; Piperazines; Polyadenylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-mos; Purines; RNA, Messenger; Roscovitine | 2008 |
Activation of Aurora-A is essential for neuronal migration via modulation of microtubule organization.
Topics: Amiodarone; Analysis of Variance; Animals; Animals, Newborn; Aurora Kinase A; Aurora Kinases; Bromodeoxyuridine; Calcium-Binding Proteins; Carrier Proteins; Cell Cycle Proteins; Cell Movement; Cells, Cultured; Cerebellum; Cyclin-Dependent Kinase 5; Enzyme Inhibitors; Female; Gene Expression Regulation, Developmental; Green Fluorescent Proteins; Male; Mice; Mice, Transgenic; Microscopy, Confocal; Microtubule-Associated Proteins; Microtubules; Mutation; Neurons; Phosphorylation; Piperazines; Pregnancy; Protein Serine-Threonine Kinases; Purines; RNA, Small Interfering; Roscovitine; Sex Factors; Signal Transduction | 2012 |
Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles.
Topics: Animals; Cell Line, Tumor; HEK293 Cells; Hepatocytes; Host-Parasite Interactions; Humans; Indoles; Liver; Malaria; Mice; Piperazines; Plasmodium yoelii; Protein Kinase Inhibitors; Protein Kinases; Purines; Pyrroles; RNA Interference; Roscovitine; Sporozoites; Sunitinib | 2017 |